These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 37575217)
1. Current advances of liquid biopsies in prostate cancer: Molecular biomarkers. Alahdal M; Perera RA; Moschovas MC; Patel V; Perera RJ Mol Ther Oncolytics; 2023 Sep; 30():27-38. PubMed ID: 37575217 [TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
3. Emerging Role of Exosomes in Liquid Biopsy for Monitoring Prostate Cancer Invasion and Metastasis. Gao Z; Pang B; Li J; Gao N; Fan T; Li Y Front Cell Dev Biol; 2021; 9():679527. PubMed ID: 34017837 [TBL] [Abstract][Full Text] [Related]
4. miR-20b-5p is a novel biomarker for detecting prostate cancer. Zhai TY; Dou M; Ma YB; Wang H; Liu F; Zhang LD; Chong T; Wang ZM; Xue L Oncol Lett; 2022 Dec; 24(6):426. PubMed ID: 36311688 [TBL] [Abstract][Full Text] [Related]
5. Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis. Barceló M; Castells M; Bassas L; Vigués F; Larriba S Sci Rep; 2019 Sep; 9(1):13772. PubMed ID: 31551516 [TBL] [Abstract][Full Text] [Related]
6. PCA3 and TMPRSS2-ERG gene fusions as diagnostic biomarkers for prostate cancer. Yang Z; Yu L; Wang Z Chin J Cancer Res; 2016 Feb; 28(1):65-71. PubMed ID: 27041928 [TBL] [Abstract][Full Text] [Related]
7. Circulating MicroRNAs as Biomarkers for Prostate Cancer Detection and Metastasis Development Prediction. Bidarra D; Constâncio V; Barros-Silva D; Ramalho-Carvalho J; Moreira-Barbosa C; Antunes L; Maurício J; Oliveira J; Henrique R; Jerónimo C Front Oncol; 2019; 9():900. PubMed ID: 31572685 [TBL] [Abstract][Full Text] [Related]
8. Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers. Filella X; Foj L Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27792187 [TBL] [Abstract][Full Text] [Related]
9. Urine-derived exosomal PSMA is a promising diagnostic biomarker for the detection of prostate cancer on initial biopsy. Wang CB; Chen SH; Zhao L; Jin X; Chen X; Ji J; Mo ZN; Wang FB Clin Transl Oncol; 2023 Mar; 25(3):758-767. PubMed ID: 36266386 [TBL] [Abstract][Full Text] [Related]
10. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone. Salido-Guadarrama AI; Morales-Montor JG; Rangel-Escareño C; Langley E; Peralta-Zaragoza O; Cruz Colin JL; Rodriguez-Dorantes M Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843 [TBL] [Abstract][Full Text] [Related]
11. Clinical utility of emerging biomarkers in prostate cancer liquid biopsies. Boerrigter E; Groen LN; Van Erp NP; Verhaegh GW; Schalken JA Expert Rev Mol Diagn; 2020 Feb; 20(2):219-230. PubMed ID: 31577907 [No Abstract] [Full Text] [Related]
13. Identification of Urinary Exosomal miRNAs for the Non-Invasive Diagnosis of Prostate Cancer. Li Z; Li LX; Diao YJ; Wang J; Ye Y; Hao XK Cancer Manag Res; 2021; 13():25-35. PubMed ID: 33442291 [TBL] [Abstract][Full Text] [Related]
14. A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10ng/ml at Initial Biopsy. McKiernan J; Donovan MJ; Margolis E; Partin A; Carter B; Brown G; Torkler P; Noerholm M; Skog J; Shore N; Andriole G; Thompson I; Carroll P Eur Urol; 2018 Dec; 74(6):731-738. PubMed ID: 30237023 [TBL] [Abstract][Full Text] [Related]
15. The potential of cell-free and exosomal microRNAs as biomarkers in liquid biopsy in patients with prostate cancer. de Nóbrega M; Dos Reis MB; Pereira ÉR; de Souza MF; de Syllos Cólus IM J Cancer Res Clin Oncol; 2022 Oct; 148(10):2893-2910. PubMed ID: 35922694 [TBL] [Abstract][Full Text] [Related]
16. Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role. Cochetti G; Poli G; Guelfi G; Boni A; Egidi MG; Mearini E Onco Targets Ther; 2016; 9():7545-7553. PubMed ID: 28008272 [TBL] [Abstract][Full Text] [Related]
17. Current landscape of exosomal non-coding RNAs in prostate cancer: Modulators and biomarkers. Li Y; Tang X; Wang B; Chen M; Zheng J; Chang K Noncoding RNA Res; 2024 Dec; 9(4):1351-1362. PubMed ID: 39247145 [TBL] [Abstract][Full Text] [Related]
18. Urinary extracellular vesicles miRNA-A new era of prostate cancer biomarkers. Jain G; Das P; Ranjan P; Neha ; Valderrama F; Cieza-Borrella C Front Genet; 2023; 14():1065757. PubMed ID: 36741322 [TBL] [Abstract][Full Text] [Related]
19. Exosomal long noncoding RNA HOXD-AS1 promotes prostate cancer metastasis via miR-361-5p/FOXM1 axis. Jiang Y; Zhao H; Chen Y; Li K; Li T; Chen J; Zhang B; Guo C; Qing L; Shen J; Liu X; Gu P Cell Death Dis; 2021 Dec; 12(12):1129. PubMed ID: 34864822 [TBL] [Abstract][Full Text] [Related]
20. Clinical use of novel urine and blood based prostate cancer biomarkers: a review. Dijkstra S; Mulders PF; Schalken JA Clin Biochem; 2014 Jul; 47(10-11):889-96. PubMed ID: 24177197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]